The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.
“FDA has not yet developed action plans to fully address travel, workload, and work-life balance because potential solutions ...
The environmental lawyer’s many controversial statements are rallying state lawmakers to pay close attention to Connecticut’s ...
(Irwin, 11/13) Yahoo Finance: Hims & Hers Launches GLP-1 Tracker In Response To FDA's Shortage Decision Hims & Hers is launching ... would have protected the right to contraception and in 2021 ...
The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...